The Overnight Low-Dose Dexamethasone Suppression Test Can Be Used to Evaluate Patients With Chronic Kidney Disease

被引:0
|
作者
Raff, Hershel [1 ,2 ,3 ]
机构
[1] Med Coll Wisconsin, Dept Med, Div Endocrinol & Mol Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Surg & Physiol, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Endocrinol Res M4150,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
关键词
Cushing syndrome; nonneoplastic hypercortisolism; chronic kidney disease; end-stage renal disease; late-night salivary cortisol; urine free cortisol; SALIVARY CORTISOL;
D O I
10.1210/jendso/bvae007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Effect of phenobarbitone on the low-dose dexamethasone suppression test and the urinary corticoid: creatinine ratio in dogs
    Foster, SF
    Church, DB
    Watson, ADJ
    AUSTRALIAN VETERINARY JOURNAL, 2000, 78 (01) : 19 - 23
  • [32] Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation
    Ceccato, F.
    Artusi, C.
    Barbot, M.
    Lizzul, L.
    Pinelli, S.
    Costantini, G.
    Niero, S.
    Antonelli, G.
    Plebani, M.
    Scaroni, C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (08) : 1105 - 1113
  • [33] The Very Low-Dose Dexamethasone Suppression Test in the General Population: A Cross-Sectional Study
    Direk, Nese
    Dekker, Marieke J. H. J.
    Luik, Annemarie I.
    Kirschbaum, Clemens
    de Rijke, Yolanda B.
    Hofman, Albert
    Hoogendijk, Witte J. G.
    Tiemeier, Henning
    PLOS ONE, 2016, 11 (10):
  • [34] URINARY CORTISOL-LEVELS IN LOW-DOSE DEXAMETHASONE SUPPRESSION TEST DISTINGUISH CUSHINGS PATIENTS FROM NORMAL CONTROLS
    KANEJOHNSON, NJ
    KENDALL, JW
    COOK, DM
    CLINICAL RESEARCH, 1985, 33 (01): : A27 - A27
  • [35] The low dose dexamethasone suppression test: Effect of time of administration and dose
    C. Barton
    S. March
    G. A. Wittert
    Journal of Endocrinological Investigation, 2002, 25 : RC10 - RC12
  • [36] The low dose dexamethasone suppression test: Effect of time of administration and dose
    Barton, C
    March, S
    Wittert, GA
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (04) : RC10 - RC12
  • [37] The role of combined low-dose dexamethasone suppression test and desmopressin stimulation test in the diagnosis of persistent Cushing's disease. Case report
    Witek, Przemyslaw
    Zgliczynski, Wojciech
    Zielinski, Grzegorz
    Jeske, Wojciech
    ENDOKRYNOLOGIA POLSKA, 2010, 61 (03) : 312 - 317
  • [38] Influence of chronic kidney disease on upper gastrointestinal bleeding in patients taking low-dose aspirin
    Lu Guo-Tao
    Lan Yu
    Zheng Mei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 318 - 318
  • [39] Safety and efficacy of low-dose rivaroxaban in Asian patients with atrial fibrillation and chronic kidney disease
    Liu, L.
    Tseng, Y. J.
    Lin, P. L.
    Chiou, W. R.
    Lee, Y. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3375 - 3375
  • [40] Low-dose atorvastatin in severe chronic kidney disease patients:: A randomized, controlled endpoint study
    Stegmayr, BG
    Brännström, M
    Bucht, S
    Crougneau, V
    Dimeny, E
    Ekspong, A
    Eriksson, M
    Granroth, B
    Gröntoft, KC
    Hadimeri, H
    Holmberg, B
    Ingman, B
    Isaksson, B
    Johansson, G
    Lindberger, K
    Lundberg, L
    Mikaelsson, L
    Olausson, E
    Persson, B
    Stenlund, H
    Wikdahl, AM
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 (06): : 489 - 497